Index of reports
> Cases with Hypertension (68)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zyprexa (Olanzapine) where reactions include hypertension. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 68 Next >>
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from France on 2012-08-03
Patient: male
Reactions: Mydriasis, Respiratory Disorder, Central Nervous System Lesion, Ischaemic Stroke, Cerebellar Syndrome, Cerebellar Haematoma, Bladder Dilatation, Pulmonary Congestion, Depression, Hypertension, Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Risperdal; Polyethylene Glycol; Tercian; Loxapine HCL; Risperdal Consta; Escitalopram; Risperdal; Lepticur; Imovane
Possible Zyprexa side effects in female
Reported by a consumer/non-health professional from Japan on 2012-08-02
Patient: female
Reactions: Maternal Drugs Affecting Foetus, Hellp Syndrome, Exposure During Breast Feeding, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cymbalta
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2012-04-25
End date: 2012-07-03
Cymbalta
Dosage: 20 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-02-23
End date: 2011-03-08
Cymbalta
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2012-03-28
End date: 2012-04-24
Cymbalta
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-22
Zyprexa
Dosage: 20 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-01-23
End date: 2011-09-05
Cymbalta
Dosage: 60 mg, unk
Administration route: Oral
Start date: 2011-03-23
End date: 2012-03-01
Cymbalta
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2012-07-04
Other drugs received by patient: Loramet; Sediel; Goodmin; Amoban; Seroquel; Alprazolam; Sepazon
Possible Zyprexa side effects in 19 year old male
Reported by a physician from Switzerland on 2012-07-31
Patient: 19 year old male
Reactions: Agitation, Yawning, Hallucination, Auditory, Dementia, Tachycardia, Hypotension, Opisthotonus, Encephalopathy, Abnormal Behaviour, Speech Disorder, Bradycardia, Gait Disturbance, Altered State of Consciousness, Hypertension, Acute Disseminated Encephalomyelitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Haloperidol; Haloperidol
Possible Zyprexa side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: 42 year old female
Reactions: Type 2 Diabetes Mellitus, Vision Blurred, Hypertension, Metabolic Syndrome
Drug(s) suspected as cause:
Risperdal
Start date: 2006-07-01
End date: 2007-01-01
Zyprexa
Indication: Mental Disorder
Start date: 1998-12-01
End date: 2006-06-01
Risperdal
Indication: Schizophrenia
Start date: 1994-11-23
Zyprexa
Start date: 2000-02-08
Seroquel
Dosage: 100 mg to 400 mg daily
Administration route: Oral
Start date: 1999-10-13
Seroquel
Dosage: 25mg, 100mg, 200mg and 300mg
Administration route: Oral
Start date: 2000-10-01
End date: 2002-03-01
Other drugs received by patient: Ranitidine; Tricor; Vesicare; Klonopin; Ranitidine; Niaspan; Lithium Carbonate; Cogentin; Mavik; Lisinopril; Enalapril Maleate; Aspirin; Paxil; Lithobid
Possible Zyprexa side effects in 81 year old male
Reported by a consumer/non-health professional from Mexico on 2012-07-25
Patient: 81 year old male
Reactions: Pneumonia, Cardio-Respiratory Arrest, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Analgesics; Antibiotics; Midazolam
Possible Zyprexa side effects in female
Reported by a consumer/non-health professional from Japan on 2012-07-18
Patient: female
Reactions: Maternal Drugs Affecting Foetus, Hellp Syndrome, Exposure During Breast Feeding, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cymbalta
Dosage: 20 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-02-23
End date: 2011-03-08
Cymbalta
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2012-03-28
End date: 2012-04-24
Cymbalta
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-22
Cymbalta
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2012-04-25
End date: 2012-07-03
Zyprexa
Dosage: 20 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-01-23
End date: 2011-09-05
Cymbalta
Dosage: 60 mg, unk
Administration route: Oral
Start date: 2011-03-23
End date: 2012-03-01
Cymbalta
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2012-07-04
Other drugs received by patient: Seroquel; Sepazon; Goodmin; Alprazolam; Loramet; Sediel; Amoban
Possible Zyprexa side effects in female
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-07-11
Patient: female, weighing 100.0 kg (220.0 pounds)
Reactions: Off Label Use, Tachycardia, Pulmonary Oedema, General Physical Health Deterioration, Hypertension, Cardiac Failure Congestive
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Equanil; Lanitop; Diazepam; Depakene; Zonadin; Iruzid / 06400701 /
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Zyprexa side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Zyprexa side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Zyprexa side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Zyprexa side effects in female
Reported by a consumer/non-health professional from France on 2012-05-29
Patient: female
Reactions: Confusional State, Abnormal Behaviour, Fall, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Dosage: 5 mg, qd
Start date: 2012-01-24
Zyprexa
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2012-01-11
End date: 2012-01-20
Other drugs received by patient: Acetaminophen; Vitamin D; Mirtazapine; Aspirin; Moviprep; Memantine Hydrochloride; Imovane; Escitalopram; Oxazepam; Furadantin; Memantine Hydrochloride
Possible Zyprexa side effects in female
Reported by a physician from France on 2012-05-15
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Hypercholesterolaemia, Pneumonia Aspiration, Type 2 Diabetes Mellitus, Central Obesity, Hyponatraemia, Pyrexia, Hypertension, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Zopiclone
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Possible Zyprexa side effects in 56 year old female
Reported by a consumer/non-health professional from Sweden on 2012-04-25
Patient: 56 year old female
Reactions: Death, LIP and / or Oral Cavity Cancer, Pneumonia, Empyema, Multiple Sclerosis, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Zyprexa
Dosage: 10 mg, qd
Administration route: Oral
Indication: Bipolar Disorder
End date: 2011-11-12
Olanzapine
Dosage: unk
Indication: Bipolar Disorder
Start date: 2011-11-16
Other drugs received by patient: Seroquel; Lithionit; Seroquel
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Zyprexa side effects in 88 year old female
Reported by a physician from France on 2012-03-21
Patient: 88 year old female
Reactions: Confusional State, Abnormal Behaviour, Hypertension, Aggression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2012-01-11
End date: 2012-01-20
Zyprexa
Dosage: 5 mg, qd
Start date: 2012-01-24
Other drugs received by patient: Vitamin D; Oxazepam; Memantine Hydrochloride; Memantine Hydrochloride; Moviprep; Furadantin; Aspirin; Mirtazapine; Imovane; Escitalopram Oxalate; Acetaminophen
Possible Zyprexa side effects in female
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-03-14
Patient: female, weighing 100.0 kg (220.0 pounds)
Reactions: Off Label Use, Tachycardia, General Physical Health Deterioration, Pulmonary Oedema, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Zonadin; Diazepam; Lanitop; Equanil; Depakene; Iruzid / 06400701 /
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-12
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Possible Zyprexa side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-08
Patient: female
Reactions: Hypertrophic Cardiomyopathy, Prinzmetal Angina, Ear Infection, Coronary Artery Disease, Hyperlipidaemia, Neuropathy Peripheral, Dizziness, Type 1 Diabetes Mellitus, Acute Coronary Syndrome, Hypertension, Acute Myocardial Infarction, Gastrooesophageal Reflux Disease, Metabolic Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Amitriptyline HCL; Lotension; Triavil; Haldol; Diltiazem HCL
Possible Zyprexa side effects in male
Reported by a physician from United States on 2012-03-08
Patient: male
Reactions: Blood Alkaline Phosphatase Increased, Gingivitis, Cellulitis, Diabetes Mellitus, Tooth Infection, Rash, Onychomycosis, Wound Haemorrhage, Weight Increased, Hyperlipidaemia, Overdose, Tardive Dyskinesia, Sinusitis, Hypertension, Hepatitis B
Drug(s) suspected as cause:
Zyprexa
Dosage: 5 mg, prn
Administration route: Oral
Indication: Schizophrenia
Zyprexa
Dosage: 20 mg, each evening
Administration route: Oral
Zyprexa
Dosage: 15 mg, each evening
Other drugs received by patient: Topamax; Topiramate; Celexa; Seroquel; Abilify; Geodon; Fosamax; Hydroxyzine; Clozaril; Forteo
Possible Zyprexa side effects in 56 year old female
Reported by a consumer/non-health professional from Sweden on 2012-03-08
Patient: 56 year old female
Reactions: Death, LIP and / or Oral Cavity Cancer, Pneumonia, Empyema, Multiple Sclerosis, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Zyprexa
Dosage: 10 mg, qd
Administration route: Oral
Indication: Bipolar Disorder
End date: 2011-11-12
Olanzapine
Indication: Bipolar Disorder
Other drugs received by patient: Seroquel; Lithionit; Seroquel
Possible Zyprexa side effects in female
Reported by a physician from United States on 2012-03-05
Patient: female
Reactions: Pancreatitis Acute, Diabetes Mellitus, Haematuria, Renal Cyst, Weight Increased, Renal Failure, Pancreatitis, Diabetic Ketoacidosis, Sleep Apnoea Syndrome, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Advair Diskus 100 / 50; Lexapro
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-05
Patient: male
Reactions: Akathisia, Glomerulonephritis Chronic, Type 2 Diabetes Mellitus, Hallucination, Auditory, Suicidal Ideation, Weight Increased, Hyperlipidaemia, Homicidal Ideation, Gastrooesophageal Reflux Disease, Hypertension, Head Titubation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Dosage: 5 mg, each evening
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2002-10-02
Zyprexa
Dosage: 15 mg, each evening
Administration route: Oral
End date: 2005-01-01
Zyprexa
Dosage: 20 mg, each evening
Administration route: Oral
Zyprexa
Dosage: 10 mg, each evening
Administration route: Oral
Other drugs received by patient: Benztropine Mesylate; Haldol; Benzodiazepine Derivatives; Risperdal; Klonopin; Venlafaxine HCL
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-02
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Pain, Quality of Life Decreased, Muscle Tightness, Neck Pain, Social Avoidant Behaviour, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2009-01-01
Possible Zyprexa side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-27
Patient: female
Reactions: Diabetes Mellitus, Pancreatic Carcinoma, Hypoglycaemia, Vaginal Haemorrhage, Hyperlipidaemia, Syncope, Chest Pain, Pancreatitis, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Zoloft; Cogentin; Trazodone HCL; Haldol
Possible Zyprexa side effects in
Reported by a consumer/non-health professional from United States on 2012-02-23
Patient:
Reactions: Drug Ineffective, Tinea Versicolour, Oral Herpes, Tinea Pedis, Viith Nerve Paralysis, Dermatitis Contact, Weight Increased, Upper Respiratory Tract Infection, Liver Function Test Abnormal, Type 1 Diabetes Mellitus, Gastrooesophageal Reflux Disease, Pain in Extremity, Tinea Cruris, non-Cardiac Chest Pain, Convulsion, Hyperlipidaemia, Pericarditis, Bronchitis, Sinus Tachycardia, Hypertension
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Paxil; Prozac; Clonidine; Haldol; Doxepin HCL; Valproic Acid; Remeron; Geodon; Aspirin; Risperdal; Ativan; Stelazine; Depakote; Nortriptyline Hydrochloride
Page 1 Next >>
|